Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119,358,581
-
Total 13F shares
-
105,856,945
-
Share change
-
+10,795,263
-
Total reported value
-
$4,159,716,153
-
Put/Call ratio
-
37%
-
Price per share
-
$39.29
-
Number of holders
-
255
-
Value change
-
+$425,134,262
-
Number of buys
-
146
-
Number of sells
-
87
Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q2 2022
As of 30 Jun 2022,
CYTOKINETICS INC - COMMON STOCK (CYTK) was held by
255 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
105,856,945 shares.
The largest 10 holders included
BlackRock Inc., FMR LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, Polar Capital Holdings Plc, LORD, ABBETT & CO. LLC, RTW INVESTMENTS, LP, and PFM Health Sciences, LP.
This page lists
255
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.